You just read:

CureFAKtor Pharmaceuticals Demonstrates Novel Focal Adhesion Kinase (FAK) Inhibitor C4 Analogs Inhibited Pancreatic Cancer Tumor Growth as Single Agents

News provided by

CureFAKtor Pharmaceuticals, LLC

Nov 14, 2011, 08:45 ET